← Leaderboards
Yu Jing Jan Heng
Beth Israel Deaconess Medical Center
$417,870
Attributed
$835,740
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $590.3K · FY2022–23$1M$750K$500K$250K$0
'22
'23
Funding mix
By agency
NIH$835,740 · 2
By mechanism
R21$535,800 · 1
R56$299,940 · 1
Top collaborators
- Gerburg M Wulf4 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Gerburg M Wulf$4,301,499
Others in their field
Other Rising Stars on “Mouse Model”
- Suma Babu · Massachusetts General Hospital$25,017,559
- Sabrina Paganoni · Massachusetts General Hospital$25,017,559
- Warwick Britton · University Of Sydney$10,964,476
- Lisa Wagar · University Of California-Irvine$5,972,985
- John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc.$5,881,537
- Fergal James Martin · University Of California Santa Cruz$5,089,409
Research focus
Mouse ModelTumorGuidelinesMalignant Breast NeoplasmTreatment OutcomeEstrogen TherapyEmotional DistressGonadal Steroid HormonesMaleCommunitiesTransfeminineTransgenderBody ImageEstrogen Receptor PositiveAffectCis-FemaleBreastCancer TherapyCis-MaleDiagnosisBreast Cancer TreatmentCancer RiskAlpelisibWell In Self
Grant awards (4)
Gender-Affirming Testosterone Therapy on Breast Cancer Risk and Treatment Outcomes$299,940
R56 · FY2023 · CA · contact PI
Gender-affirming estrogen therapy and breast cancer treatment outcome$200,442
R21 · FY2023 · CA · contact PI
Admin Suppl Gender-affirming estrogen therapy and breast cancer treatment outcome$89,920
R21 · FY2023 · CA · contact PI
Gender-affirming estrogen therapy and breast cancer treatment outcome$245,438
R21 · FY2022 · CA · contact PI